Literature DB >> 26844385

Case Report of an Hepatoid Adenocarcinoma of the Stomach.

Raffaele Gaeta1, Clara Ugolini, Maura Castagna.   

Abstract

Hepatoid adenocarcinoma (HAC) is a rare but important type of extrahepatic tumor that has a morphologic similarity to hepatocellular carcinoma, with production of α-fetoprotein in high amounts and a poor prognosis. Stomach is one of the organs in which HAC has been most commonly identified. We report a case of an old man with a polypoid mass in the prepyloric region. The microscopical aspects were suggestive for an undifferentiated adenocarcinoma, but the positive immunohistochemical staining for α-fetoprotein, α-1-antitrypsin, α-1-antichymotrypsin, and Hep Par1 were crucial for the final diagnosis of hepatoid adenocarcinoma of the stomach. Because of the poor prognosis for this type of tumor, correct and early-stage diagnosis of HAC is essential and long-term follow-up is required.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26844385     DOI: 10.1097/PAI.0000000000000286

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  3 in total

1.  Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series.

Authors:  Xiang-Yu Zeng; Yu-Ping Yin; Hua Xiao; Peng Zhang; Jun He; Wei-Zhen Liu; Jin-Bo Gao; Xiao-Ming Shuai; Guo-Bin Wang; Xiu-Li Wu; Kai-Xiong Tao
Journal:  Curr Med Sci       Date:  2018-12-07

Review 2.  Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments.

Authors:  Ruolan Xia; Yuwen Zhou; Yuqing Wang; Jiaming Yuan; Xuelei Ma
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

3.  Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach.

Authors:  Junjie Jiang; Yongfeng Ding; Jun Lu; Yanyan Chen; Yiran Chen; Wenyi Zhao; Wenfan Chen; Mei Kong; Chengzhi Li; Xiaodong Teng; Quan Zhou; Nong Xu; Donghui Zhou; Zhan Zhou; Haiyong Wang; Lisong Teng
Journal:  Int J Biol Sci       Date:  2022-08-29       Impact factor: 10.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.